Immunocore Holdings plc
IMCR
$27.93
-$0.59-2.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.57M | -35.51M | -29.23M | -20.31M | -21.63M |
| Total Depreciation and Amortization | 3.36M | 3.27M | 3.60M | 3.84M | 4.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.87M | 30.84M | 20.24M | 17.34M | 15.46M |
| Change in Net Operating Assets | -31.58M | -9.30M | 13.38M | 32.71M | 33.20M |
| Cash from Operations | -24.92M | -10.71M | 7.99M | 33.58M | 31.08M |
| Capital Expenditure | -5.82M | -4.34M | -5.04M | -5.12M | -5.04M |
| Sale of Property, Plant, and Equipment | -- | -- | 44.00K | 44.00K | 44.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.00M | -12.00M | -14.00M | -20.00M | -340.00M |
| Cash from Investing | -21.82M | -16.34M | -19.00M | -25.08M | -345.00M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -52.06M | -52.06M | -52.06M |
| Issuance of Common Stock | 10.48M | 12.37M | 8.64M | 6.97M | 3.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -1.12M |
| Cash from Financing | 10.48M | 12.37M | -43.42M | -45.09M | -49.58M |
| Foreign Exchange rate Adjustments | 12.10M | 26.66M | 15.08M | 19.55M | 7.52M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.17M | 11.98M | -39.35M | -17.05M | -355.98M |